Clinical Data on Hodgkin's Patients
Case . | Class . | Stage . | Status at Study . | Survival (yr) . | Notes . |
---|---|---|---|---|---|
1 | LP | IIIA | 1st relapse | 16+ | Presented @ age 31 → MOPP/DXT → CR → relapse |
2 | NS | IIIA | Presentation | 2+ | LTF |
3 | NS | IIB | Presentation | 3+ | DXT → CR |
5 | NS | IIIB | Presentation | 3+ | ABVD → CR |
6 | NS | IIA | Presentation | 3+ | DXT → CR |
7 | MC | IIA | 2nd relapse | 7 | MOPP → CR → relapse @ 3 yrs → MOPP/ABVD → demised post ABMT |
Case . | Class . | Stage . | Status at Study . | Survival (yr) . | Notes . |
---|---|---|---|---|---|
1 | LP | IIIA | 1st relapse | 16+ | Presented @ age 31 → MOPP/DXT → CR → relapse |
2 | NS | IIIA | Presentation | 2+ | LTF |
3 | NS | IIB | Presentation | 3+ | DXT → CR |
5 | NS | IIIB | Presentation | 3+ | ABVD → CR |
6 | NS | IIA | Presentation | 3+ | DXT → CR |
7 | MC | IIA | 2nd relapse | 7 | MOPP → CR → relapse @ 3 yrs → MOPP/ABVD → demised post ABMT |
Clinical outcomes of patients involved in this study.
Abbreviations: MOPP, mechlorethamine-oncovin (vincristine)-procarbazine-prednisone; ABVD, Adriamycin-bleomycin-vinblastine-dacarbazine; DXT, deep X-ray therapy; ABMT, autologous bone marrow transplant; CR, complete remission; LTF, lost to follow-up.